a developer for the treatment of central nervous system
Industry PharmaceuticalsOther
A.I.dvisor indicates that over the last year, SUPN has been loosely correlated with PETQ. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if SUPN jumps, then PETQ could also see price increases.
Ticker / NAME | Correlation To SUPN | 1D Price Change % | ||
---|---|---|---|---|
SUPN | 100% | -1.28% | ||
PETQ - SUPN | 38% Loosely correlated | -0.07% | ||
AMPH - SUPN | 32% Poorly correlated | -3.61% | ||
DVAX - SUPN | 28% Poorly correlated | -3.03% | ||
AMRX - SUPN | 28% Poorly correlated | -1.96% | ||
AQST - SUPN | 27% Poorly correlated | -7.51% | ||
More |
Ticker / NAME | Correlation To SUPN | 1D Price Change % |
---|---|---|
SUPN | 100% | -1.28% |
central nervous system theme (4 stocks) | 60% Loosely correlated | +0.50% |
treatment theme (61 stocks) | 38% Loosely correlated | +0.91% |
pharmaceuticals theme (167 stocks) | 32% Poorly correlated | +0.82% |
Pharmaceuticals theme (328 stocks) | 20% Poorly correlated | +0.11% |
Pharmaceuticals: Other theme (252 stocks) | 16% Poorly correlated | +0.05% |